tiprankstipranks
Tyra Bioscience (TYRA)
NASDAQ:TYRA
US Market
TYRA
Tyra Bioscience
RESEARCH TOOLSreports
Want to see TYRA full AI Analyst Report?

Tyra Bioscience (TYRA) Stock News & Sentiment

129 Followers
Tyra Biosciences Rated Buy on Anticipation of Interim SURF302 Dabogratinib Data in FGFR3‑Driven NMIBC
Premium
Ratings
Tyra Biosciences Rated Buy on Anticipation of Interim SURF302 Dabogratinib Data in FGFR3‑Driven NMIBC
3d ago
TYRA
Analyst Reiterates Buy on Tyra as Dabogratinib Catalysts Approach; $50 Price Target Maintained
Premium
Ratings
Analyst Reiterates Buy on Tyra as Dabogratinib Catalysts Approach; $50 Price Target Maintained
16d ago
TYRA
Buy Rating on Tyra Biosciences Backed by Dabogratinib’s Potential to Redefine Intermediate-Risk Bladder Cancer Treatment Ahead of Key Phase II SURF302 Data
Premium
Ratings
Buy Rating on Tyra Biosciences Backed by Dabogratinib’s Potential to Redefine Intermediate-Risk Bladder Cancer Treatment Ahead of Key Phase II SURF302 Data
25d ago
TYRA
Dabogratinib’s Differentiated FGFR3 Profile and SURF302 Readout Position Tyra for Upside in Intermediate‑Risk NMIBC
Premium
Ratings
Dabogratinib’s Differentiated FGFR3 Profile and SURF302 Readout Position Tyra for Upside in Intermediate‑Risk NMIBC
1M ago
TYRA
Tyra Bioscience Expands Board, Appoints New Independent Director
Premium
Company Announcements
Tyra Bioscience Expands Board, Appoints New Independent Director
1M ago
8K
TYRA
Tyra Biosciences Advances Dabogratinib Trial in Niche Urothelial Cancer: What Investors Should Watch
Premium
Company Announcements
Tyra Biosciences Advances Dabogratinib Trial in Niche Urothelial Cancer: What Investors Should Watch
1M ago
TYRA
Tyra Bioscience Strengthens Financial Leadership with New Officer
Premium
Company Announcements
Tyra Bioscience Strengthens Financial Leadership with New Officer
2M ago
8K
TYRA
More TYRA News >

TYRA News on the Web

Tyra Bioscience (TYRA) Gets a Buy from Canaccord Genuity
TipRanks News
Neutral
Tyra Biosciences Rated Buy on Anticipation of Interim SURF302 Dabogratinib Data in FGFR3‑Driven NMIBC
TipRanks News
Bullish
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish
Tyra Biosciences initiated with a Peer Perform at Wolfe Research
TipRanks News
Neutral
Why Tyra Biosciences Stock Is Sliding After Rally
TipRanks News
Neutral
Tyra Biosciences Stock Has Soared 280% in a Year. One Fund Just Disclosed Buying More Shares | The Motley Fool
Motley Fool
Bullish
Jefferies Reaffirms Their Buy Rating on Tyra Bioscience (TYRA)
TipRanks News
Bullish
Bank of America Securities Keeps Their Buy Rating on Tyra Bioscience (TYRA)
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
TYRA
Sector Average
Media Buzz
This Week2 articles
Weekly Average5.25 articles
News Sentiment
This Week100%
Sector Average79%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TYRA’s Media Buzz Sentiment?
2 articles about TYRA were published this week. In an average week, 5.25 articles are published.
    What is TYRA’s weekly average amount of articles?
    In an average week, 5.25 articles about TYRA are published.
      What is TYRA’s News Sentiment?
      100% of articles about TYRA were positive this week, compared to its sector average of 79%.
        Healthcare Stocks that are Trending in the News
        AKTXAkari Therapeutics
        IMMXImmix Biopharma
        SYSo-Young International
        ADOAnteoTech Ltd
        FSPKFFisher & Paykel Healthcare Corporation Limited
        Showing the stocks with the most bullish news sentiment over the past week